FONAR Co. (NASDAQ:FONR - Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $14.39 and traded as high as $14.98. FONAR shares last traded at $14.51, with a volume of 22,208 shares.
Analysts Set New Price Targets
Separately, Wall Street Zen raised shares of FONAR from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 19th.
View Our Latest Analysis on FONR
FONAR Stock Performance
The company has a market cap of $89.94 million, a price-to-earnings ratio of 12.61 and a beta of 0.99. The firm has a fifty day moving average price of $13.09 and a 200 day moving average price of $14.38.
FONAR (NASDAQ:FONR - Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The medical equipment provider reported $0.37 EPS for the quarter. FONAR had a net margin of 7.68% and a return on equity of 4.94%.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Empowered Funds LLC boosted its stake in shares of FONAR by 5.1% during the fourth quarter. Empowered Funds LLC now owns 19,635 shares of the medical equipment provider's stock valued at $297,000 after purchasing an additional 945 shares in the last quarter. Bridgeway Capital Management LLC grew its stake in FONAR by 1.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 80,035 shares of the medical equipment provider's stock valued at $1,212,000 after acquiring an additional 945 shares during the period. Dimensional Fund Advisors LP increased its position in shares of FONAR by 0.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 376,678 shares of the medical equipment provider's stock worth $5,703,000 after acquiring an additional 2,149 shares in the last quarter. Money Concepts Capital Corp increased its holdings in FONAR by 1.2% during the 1st quarter. Money Concepts Capital Corp now owns 406,296 shares of the medical equipment provider's stock worth $5,692,000 after purchasing an additional 4,719 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC boosted its holdings in FONAR by 16.5% during the 1st quarter. Linden Thomas Advisory Services LLC now owns 34,054 shares of the medical equipment provider's stock worth $477,000 after acquiring an additional 4,818 shares during the last quarter. 50.64% of the stock is currently owned by institutional investors and hedge funds.
FONAR Company Profile
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
See Also
Before you consider FONAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.
While FONAR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
